These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 39104521)

  • 1. Humoral immune responses primed by the alteration of gut microbiota were associated with galactose-deficient IgA1 production in IgA nephropathy.
    Gao L; Li H; Liu X; Li H; Li P; Lu W; Xie X; Lv J; Jin J
    Front Immunol; 2024; 15():1415026. PubMed ID: 39104521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population.
    Zhong Z; Tan J; Tan L; Tang Y; Qiu Z; Pei G; Qin W
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107085. PubMed ID: 33068859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of IgG antibody to galactose-deficient IgA1 in children with IgA nephropathy].
    Zhou N; Zhang H; Liu XR; Sun Q; Meng Q; Chen Z; Shen Y
    Zhonghua Er Ke Za Zhi; 2017 Sep; 55(9):663-667. PubMed ID: 28881511
    [No Abstract]   [Full Text] [Related]  

  • 4. IgA nephropathy: gut microbiome regulates the production of hypoglycosilated IgA1 via the TLR4 signaling pathway.
    Zhu Y; He H; Sun W; Wu J; Xiao Y; Peng Y; Hu P; Jin M; Liu P; Zhang D; Xie T; Huang L; He W; Wei M; Wang L; Xu X; Tang Y
    Nephrol Dial Transplant; 2024 Sep; 39(10):1624-1641. PubMed ID: 38402460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study.
    Hu X; Du J; Xie Y; Huang Q; Xiao Y; Chen J; Yan S; Gong Z; Ouyang S
    BMC Nephrol; 2020 Mar; 21(1):97. PubMed ID: 32169051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy.
    Nakata J; Suzuki Y; Suzuki H; Sato D; Kano T; Yanagawa H; Matsuzaki K; Horikoshi S; Novak J; Tomino Y
    PLoS One; 2014; 9(2):e89707. PubMed ID: 24586974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
    Rizk DV; Saha MK; Hall S; Novak L; Brown R; Huang ZQ; Fatima H; Julian BA; Novak J
    J Am Soc Nephrol; 2019 Oct; 30(10):2017-2026. PubMed ID: 31444275
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Liu XZ; Zhang YM; Jia NY; Zhang H
    Ren Fail; 2020 Nov; 42(1):539-546. PubMed ID: 32524871
    [No Abstract]   [Full Text] [Related]  

  • 9. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y; Li H; Yu H; Wang F; Jia J; Yan T
    BMC Nephrol; 2022 Jan; 23(1):25. PubMed ID: 35016642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell targeting in IgA nephropathy.
    Suzuki Y
    Nephrology (Carlton); 2024 Sep; 29 Suppl 2():39-43. PubMed ID: 39327767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
    Zhao L; Peng L; Yang D; Chen S; Lan Z; Zhu X; Yuan S; Chen G; Liu Y; Liu H
    Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin A nephropathy.
    Yamaguchi H; Goto S; Takahashi N; Tsuchida M; Watanabe H; Yamamoto S; Kaneko Y; Higashi K; Mori H; Nakamura Y; Horii A; Kurokawa K; Narita I
    Nephrol Dial Transplant; 2021 Jan; 36(1):75-86. PubMed ID: 33099625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy.
    Liu Y; Liu X; Jia J; Zheng J; Yan T
    J Transl Med; 2019 Sep; 17(1):320. PubMed ID: 31547815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut and respiratory microbiota landscapes in IgA nephropathy: a cross-sectional study.
    Yuan X; Qing J; Zhi W; Wu F; Yan Y; Li Y
    Ren Fail; 2024 Dec; 46(2):2399749. PubMed ID: 39248406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metagenomics-based systematic analysis reveals that gut microbiota Gd-IgA1-associated enzymes may play a key role in IgA nephropathy.
    Liang X; Zhang S; Zhang D; Hu L; Zhang L; Peng Y; Xu Y; Hou H; Zou C; Liu X; Chen Y; Lu F
    Front Mol Biosci; 2022; 9():970723. PubMed ID: 36090029
    [No Abstract]   [Full Text] [Related]  

  • 16. Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.
    Reily C; Ueda H; Huang ZQ; Mestecky J; Julian BA; Willey CD; Novak J
    J Immunol Res; 2014; 2014():197548. PubMed ID: 25152896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Suzuki H; Yasutake J; Makita Y; Tanbo Y; Yamasaki K; Sofue T; Kano T; Suzuki Y
    Kidney Int; 2018 Mar; 93(3):700-705. PubMed ID: 29329643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Characteristics of IgA Nephropathy With Minimal Change Disease.
    Li H; Lu W; Li H; Liu X; Zhang X; Xie L; Lan P; Yu X; Dai Y; Xie X; Lv J
    Front Pharmacol; 2021; 12():793511. PubMed ID: 34975488
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
    Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.
    Zachova K; Jemelkova J; Kosztyu P; Ohyama Y; Takahashi K; Zadrazil J; Orsag J; Matousovic K; Galuszkova D; Petejova N; Mestecky J; Raska M
    J Am Soc Nephrol; 2022 May; 33(5):908-917. PubMed ID: 35115327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.